Bristol-Myers Squibb Company PFD CONV 2 BMYMP OTC

Other OTC • Healthcare • Drug Manufacturers - General • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour Bristol-Myers Squibb Company PFD CONV 2 (BMYMP), dont 32 achats et 16 ventes. Le total des achats d'initiés s'élève à $1.15M et le total des ventes d'initiés à $4.7M.

Les initiés notables ayant une activité récente comprennent Poole Ahn Amanda, Storch Gerald L, Yale Phyllis R. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — BMYMP

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2024-01-01	Poole Ahn Amanda	EVP, Chief Human Resources	Cession	4,822	-	-	-
2023-12-31	Storch Gerald L	Director	Attribution de RSU	706	-	-	82,140
2023-12-31	Yale Phyllis R	Director	Attribution de RSU	658	-	-	22,359
2023-12-31	Arduini Peter J	Director	Attribution de RSU	658	-	-	47,167
2023-12-31	Rice Derica W	Director	Attribution de RSU	706	-	-	18,401
2023-12-31	Haller Julia A	Director	Attribution de RSU	706	-	-	22,746
2023-12-31	Samuels Theodore R. Ii	Director	Attribution de RSU	950	-	-	42,103
2023-12-31	Hidalgo Medina Manuel	Director	Attribution de RSU	164	-	-	9,188
2023-12-31	Bhatt Deepak	Director	Attribution de RSU	164	-	-	5,506
2023-12-15	Hoch Lynelle	President, Cell Therapy Org.	Cession	6,304	-	-	-
2023-12-05	Boerner Christopher S.	Chief Executive Officer	Achat Informatif	2,000	$49.78	$99.56K	82,672
2023-12-02	Elkins David V	EVP, Chief Financial Officer	Exercice d'Options (Vente)	8,792	-	-	-
2023-12-02	Boerner Christopher S.	Chief Executive Officer	Exercice d'Options (Vente)	2,638	-	-	-
2023-12-02	Plenge Robert M	EVP, Chief Research Officer	Exercice d'Options (Vente)	616	-	-	-
2023-11-28	Boerner Christopher S.	Chief Executive Officer	Achat Informatif	3,071	$48.86	$150.05K	79,384
2023-11-21	Leung Sandra	EVP, General Counsel	Autre (Achat)	9,830	$48.75	$479.16K	93,436
2023-11-20	Samuels Theodore R. Ii	Director	Achat Informatif	8,500	$49.81	$423.39K	35,500
2023-11-01	Boerner Christopher S.	Chief Executive Officer	Attribution de RSU	11,858	-	-	11,858
2023-10-10	Caforio Giovanni	Board Chair and CEO	Don (Donné)	440	-	-	367,495
2023-10-02	Gallman Cari	EVP, Corporate Affairs	Cession	5,201	-	-	-
2023-10-02	Gallman Cari	EVP, Corporate Affairs	Attribution de RSU	13,675	-	-	13,675
2023-09-30	Storch Gerald L	Director	Attribution de RSU	625	-	-	80,538
2023-09-30	Yale Phyllis R	Director	Attribution de RSU	581	-	-	21,463
2023-09-30	Arduini Peter J	Director	Attribution de RSU	581	-	-	45,998
2023-09-30	Rice Derica W	Director	Attribution de RSU	625	-	-	17,500
2023-09-30	Haller Julia A	Director	Attribution de RSU	625	-	-	21,797
2023-09-30	Samuels Theodore R. Ii	Director	Attribution de RSU	840	-	-	40,701
2023-09-30	Bhatt Deepak	Director	Attribution de RSU	145	-	-	5,283
2023-08-24	Powell Ann	EVP, Chief Human Resources	Vente Informative	17,986	$61.25	$1.1M	27,868
2023-08-03	Plenge Robert M	EVP, Chief Research Officer	Vente Informative	732	$61.14	$44.75K	6,584
2023-07-03	Plenge Robert M	EVP, Chief Research Officer	Cession	14,052	-	-	-
2023-07-01	Hirawat Samit	EVP,chief Med.offr.,drug Dev.	Exercice d'Options (Vente)	9,357	-	-	-
2023-07-01	Weese Michelle	EVP, Corporate Affairs	Retenue Fiscale RSU	682	$63.95	$43.61K	3,453
2023-06-30	Storch Gerald L	Director	Attribution de RSU	567	-	-	79,180
2023-06-30	Yale Phyllis R	Director	Attribution de RSU	528	-	-	20,690
2023-06-30	Arduini Peter J	Director	Attribution de RSU	528	-	-	45,000
2023-06-30	Rice Derica W	Director	Attribution de RSU	567	-	-	16,721
2023-06-30	Haller Julia A	Director	Attribution de RSU	554	-	-	20,978
2023-06-30	Samuels Theodore R. Ii	Director	Attribution de RSU	762	-	-	39,495
2023-06-30	Bhatt Deepak	Director	Attribution de RSU	127	-	-	5,091
2023-06-03	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercice d'Options (Vente)	1,077	-	-	-
2023-05-03	Vessey Rupert	EVP & President, Research	Vente Informative	50,385	$67.06	$3.38M	47,751
2023-05-02	Greenlees Sharon	SVP & Controller	Retenue Fiscale RSU	227	$68.10	$15.46K	400
2023-05-01	Lenkowsky Adam	EVP, Chief Commercial Officer	Attribution de RSU	5,494	-	-	5,494
2023-04-26	Lenkowsky Adam	EVP, Chief Commercial Officer	Inconnu	3,580	-	-	-
2023-04-01	Mily Elizabeth	EVP, Strategy & Bd	Exercice d'Options (Vente)	2,684	-	-	2,685
2023-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Retenue Fiscale RSU	1,692	$69.31	$117.27K	3,226
2023-03-31	Storch Gerald L	Director	Attribution de RSU	523	-	-	77,963
2023-03-31	Yale Phyllis R	Director	Attribution de RSU	487	-	-	19,996
2023-03-31	Arduini Peter J	Director	Attribution de RSU	487	-	-	44,104

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration